Business Wire

SOSAFE

Share
SoSafe Appoints Dropbox Senior Executive Laura Ryan as Chief People Officer

SoSafe, Europe’s largest security awareness and human risk management vendor, has appointed seasoned HR executive Laura Ryan as Chief People Officer to support the organisation as they continue to scale operations internationally in the face of rising global cyber security threats.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240604322632/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Laura Ryan appointed as new Chief People Officer at largest security awareness and human risk management platform SoSafe. (Photo: Business Wire)

Laura will lead SoSafe’s people function, overseeing the development of a best-in-class team to help deliver the company’s next chapter of strategic growth. She will manage human resources, people and talent, workspace and community, and operations, acting as an engine to accelerate the company’s mission and long-term vision to strengthen digital self-defence.

With over 20 years of hands-on experience in the technology and financial services industries, Laura has actively supported the evolution of HR functions. Prior to joining SoSafe, she worked almost nine years at Dropbox, most recently as Vice President Global HR Business Partnering. Prior to this, Laura spent over five years at Google and over seven years in Financial Services in a number of HR roles, honing her HR craft.

Laura Ryan, incoming Chief People Officer at SoSafe: “Throughout my career I've been passionate about scaling organisations, helping companies achieve this by fostering innovation and creating workplaces that inspire people to do their best work. SoSafe is working in an extremely interesting market with very strong dynamics: Cybercrime is the biggest threat to organisations and SoSafe delivers a human-centric solution based on psychology. This gives the company and the team a very strong purpose and I am very excited to contribute to their mission to empower people facing digital threats.”

SoSafe is currently leading the category evolution from security awareness and training to human risk management through product innovation, accelerating its sustainable growth. Since the beginning of 2022, they have grown from 180 employees in Cologne, Germany, to 500 employees across nine locations in Europe with around 100 open positions, recently adding two additional office hubs in Dublin, Ireland, and Chemnitz, Germany.

Dr Niklas Hellemann, CEO of SoSafe: "One of the pillars of our success is the excellence of our people - we are proud to have an outstanding team to drive our ambitious plans. Laura brings a wealth of experience in fast-paced, multi-cultural organisations and has proven her ability to build and lead people divisions in high growth technology companies. I am very excited to have her join our management team and look forward to working with her to drive further growth for the business.”

Laura's appointment follows a series of senior hires to strengthen the company's expertise.:

  • Megan Brown joins as Vice President of Global Partnerships, bringing more than 15 years of sales experience at LogicGate, Checkster and CareerBuilder to lead SoSafe's plans to expand its channel sales through international partnerships.
  • Gina Dragulin joins as Vice President of Product Marketing to ensure that SoSafe's product innovations are brought to life and their customers get highest value. Prior to joining SoSafe, she worked for Miro, Microsoft and other tech companies while leading various marketing functions.
  • Thomas Owen joins as Chief Information Security Officer, bringing with him a wealth of experience in the security industry from companies such as Grafana Labs, iloomi and Snyk.

About SoSafe

SoSafe, founded by a team of behavioural scientists and technology experts, is the largest security awareness and human risk management vendor based in Europe. SoSafe is empowering over 4700 customers worldwide to effectively mitigate cyber risk. With a unique human-centric approach grounded in behavioural science, SoSafe enhances secure behaviour across organizations, making it intuitive and second nature. The platform is designed to strengthen digital self-defence by creating robust security cultures that actively involve employees in mitigating human risks. By leveraging psychology and advanced technology and AI, it enables security professionals to effectively identify, prioritize, manage, and ultimately reduce their human risk. The SoSafe team now consists of more than 500 employees in nice locations: Cologne (headquarters), Amsterdam, Berlin, Chemnitz, Dublin, London, Paris, Lisbon, and Munich.

Website: www.sosafe-awareness.com/
LinkedIn: www.linkedin.com/company/sosafe-cyber-security/mycompany/

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240604322632/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release

Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem

Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 11:08:00 CET | Press release

Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played

Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 10:44:00 CET | Press release

At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will

Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 10:00:00 CET | Press release

Anthropic’s safety-first AI meets Allianz's dedication to customer centricity, stakeholder trust, and regulatory excellenceThree focus areas of the partnership: workforce empowerment, operations automation through agentic AI, and regulatory compliance Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE.

MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 07:00:00 CET | Press release

MH002 is currently the most advanced Live Biotherapeutic Product (LBP) based on a rationally-designed combination of disease specific bacteria (microbial consortia), for the treatment of inflammatory bowel diseases (IBD) STARFISH-UC Phase 2b trial is designed to confirm MH002’s early efficacy signals and favorable safety observed in Phase 2a studies MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye